
KovaDx provides an affordable point-of-care diagnostic that makes screening and monitoring of sickle cell disease and other hemolytic anemias more accessible. The device uses Quantitative Phase Imaging to capture label-free red blood cell images and applies deep learning models to detect and quantify disease-related morphologies. KovaDx is positioned as a medical diagnostics product for clinics and community health settings, enabling faster results at the point of care. The solution targets areas with high disease burden to expand screening capacity and reduce care gaps in low-resource environments.

KovaDx provides an affordable point-of-care diagnostic that makes screening and monitoring of sickle cell disease and other hemolytic anemias more accessible. The device uses Quantitative Phase Imaging to capture label-free red blood cell images and applies deep learning models to detect and quantify disease-related morphologies. KovaDx is positioned as a medical diagnostics product for clinics and community health settings, enabling faster results at the point of care. The solution targets areas with high disease burden to expand screening capacity and reduce care gaps in low-resource environments.